Jardiance (empagliflozin) improving CV outcomes

January 2017

We told you about Jardiance (empagliflozin) improving CV outcomes in Nov 2015....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cardiology Recommend Limiting Dose and Duration of NSAIDs in High-CV-Risk Patients
Opioids Be Ready to Help More Patients Use Buprenorphine/Naloxone
Acne Know When to Recommend New OTC Differin 0.1% Gel for Acne
Diabetes Adlyxin and Soliqua Join a Crowded Market of Injectable Diabetes Meds
Vaccines Explain Why Women Should Get Pertussis Vaccine With Every Pregnancy
Inhalers Prevent Common Inhaler Errors
Calcium Help Patients Use Calcium Supplements Safely
Pediatrics Suggest Systemic Quinolones Only Rarely in Kids...But Not Due to Joint Concerns
Dehydration Consider Diluted Apple Juice an Option for Mild Dehydration in Kids
End-of-Life Care Provide Options to Enhance End-of-Life Care
Obesity & Weight Loss Explain How Lomaira and Belviq XR Stack Up Against Other Weight Loss Meds
Practice Jardiance (empagliflozin) improving CV outcomes
Insurance Prioritize Urgent Prior Auth Requests to Avoid Gaps in Therapy